Frazier Life Sciences Announces Addition of Veteran Drug Developer and Entrepreneur to Team
MENLO PARK, Calif., Oct. 31, 2023 /PRNewswire/ -- Frazier Life Sciences (FLS) is excited to introduce Scott Wasserman, M.D.
- MENLO PARK, Calif., Oct. 31, 2023 /PRNewswire/ -- Frazier Life Sciences (FLS) is excited to introduce Scott Wasserman, M.D.
- as the latest member of its venture partners team, bringing more than two decades of expertise in drug development across diverse therapeutic areas.
- "Scott's proficiency and unwavering commitment to scientific rigor in drug development perfectly complements Frazier Life Sciences' data-driven methodology, underscoring our aligned missions."
- "I'm delighted to join Frazier Life Sciences and contribute to the company's proven approach to venture creation," remarks Scott Wasserman, M.D., venture partner at FLS.